Stereotaxis Announces Q3 2025 Financial Results and Call Details
Stereotaxis to Share Third Quarter 2025 Financial Performance
ST. LOUIS, October 21, 2025 – Stereotaxis (NYSE: STXS), a pioneer in surgical robotics for minimally invasive endovascular interventions, is set to release its financial results for the third quarter of 2025. This announcement will take place on November 11, following the close of U.S. financial markets. Interested parties can expect a comprehensive update that reflects the company’s ongoing efforts and financial health.
Details of the Upcoming Conference Call
The company will host a conference call and webcast at 4:30 p.m. ET on the same day. This will be a valuable opportunity for stakeholders to engage directly with Stereotaxis' leadership. The management team will discuss the company's recent financial performance and broader corporate developments.
How to Join the Call
To participate in the live call, dial 800-715-9871 (US and Canada) or 646-307-1963 (International). Don’t forget to provide the participant pass code 4402192 for access. This ensures that all interested investors and partners can join the conversation and gain insights into the company’s strategies and results.
Accessing the Live Webcast
In addition to the dial-in option, Stereotaxis will provide a live webcast of the call. Interested individuals can find the necessary details and access the webcast through the investor relations section of the Stereotaxis website.
Replaying the Conference Call
For those unable to join the call live, a replay will be available starting approximately four hours after the conclusion of the initial call. This will remain accessible for one month, allowing ample time for stakeholders to catch up on the discussed topics and outcomes.
About Stereotaxis
Stereotaxis (NYSE: STXS) leads the way in innovative surgical robotics tailored for minimally invasive endovascular procedures. The dedication to advancing their robotic technologies ensures that physicians can deliver exceptional patient care with enhanced precision and safety. With their state-of-the-art systems and instruments, Stereotaxis seeks to improve access to minimally invasive therapies while boosting operational productivity and connectivity within the interventional laboratory. To date, Stereotaxis technology has been utilized in over 150,000 patient procedures across various global markets.
Contact Information for Investors
For inquiries, the main contacts at Stereotaxis are:
David L. Fischel, Chairman and Chief Executive Officer
Kimberly Peery, Chief Financial Officer
314-678-6100
Investors@Stereotaxis.com
Frequently Asked Questions
What is the date of Stereotaxis' third quarter financial results report?
Stereotaxis will report its third quarter financial results on November 11, 2025.
How can I participate in the Stereotaxis conference call?
Interested participants can join the conference call by dialing 800-715-9871 or 646-307-1963 with the pass code 4402192.
Where can I access the live webcast?
The live webcast can be accessed on the investor relations section of the Stereotaxis website.
Will there be a replay of the conference call?
Yes, a replay will be available starting four hours after the call, for one month.
What is the mission of Stereotaxis?
Stereotaxis aims to develop innovative robotic systems that enhance patient care and improve minimally invasive procedures.
About The Author
Contact Dominic Sanders privately here. Or send an email with ATTN: Dominic Sanders as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.
